BOSTON SCIENTIFIC CORPORATION Unrealized Gain (Loss) on Investments
BOSTON SCIENTIFIC CORPORATION (BSX) reported Unrealized Gain (Loss) on Investments of $178.00 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-23.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2023-02-23
- BOSTON SCIENTIFIC CORPORATION unrealized gain (loss) on investments for fiscal 2022 was $178.00M.
- BOSTON SCIENTIFIC CORPORATION unrealized gain (loss) on investments for fiscal 2021 was -$178.00M, a 149.04% decline from fiscal 2020.
- BOSTON SCIENTIFIC CORPORATION unrealized gain (loss) on investments for fiscal 2020 was $363.00M.
| Period end | Unrealized Gain (Loss) on Investments 12 month |
|---|---|
| 2022-12-31 | $178.00M 10-K · filed 2023-02-23 |
| 2021-12-31 | -$178.00M 10-K · filed 2022-02-23 |
| 2020-12-31 | $363.00M 10-K · filed 2022-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |